rise, normal, blood, components, red, white, platelets, undifferentiated, exact, copy, specific, specialized, parent, division, mature, Drug Views, drugs, Medical, Information, Health, Drugs, Conditions, Pharmacy, Pills http://www.drugviews.com/articles.php en-us Ateom.com - Website Power Tools medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014.]]> Thu, 02 Sep 2010 00:38:00 -0400 http://www.drugviews.com/articles.php?t=TriMark-predicts-regenerative-medicine-products-will-exceed-3-billion-in-2010 medical research conducted to treat diseases of the brain, heart, and circulatory system is moving too slowly to help millions of patients, according to the Cell Therapy Foundation, which advocates the use of adult stem cells to dramatically impact and improve the condition of patients who suffer from a variety of conditions.]]> Tue, 31 Aug 2010 01:52:18 -0400 http://www.drugviews.com/articles.php?t=Cell-Therapy-Foundation-analysis-calls-for-funding-in-medical-research services that process and store adult stem cells, said today it has sold two BioArchive® Systems to HealthBanks Biotech Company, Ltd..]]> Mon, 30 Aug 2010 10:40:32 -0400 http://www.drugviews.com/articles.php?t=ThermoGenesis-sells-two-BioArchive-Systems-to-HealthBanks-Biotech lung tranplantation have better one-year survival when Perfadex is used as the preservation solution for donor lungs compared with UW solution. Furthermore, the patients who received lungs preserved in Perfadex ran a significantly lower risk of being affected by rejection reactions requiring ]]> Mon, 30 Aug 2010 09:54:30 -0400 http://www.drugviews.com/articles.php?t=Perfadex-improves-survival-in-lung-tranplant-patients-Study quality of life and survival in patients with chronic heart failure, according to results from the STAR-heart study.]]> Mon, 30 Aug 2010 06:15:35 -0400 http://www.drugviews.com/articles.php?t=Study-finds-bone-marrow-stem-cell-therapy-improves-efficacy-in-chronic-heart-failure store adult stem cells, said it has filed a Certificate of Amendment to its Amended and Restated Certification of Incorporation to effect its previously announced one-for-four reverse stock split of its common stock.]]> Fri, 27 Aug 2010 02:51:16 -0400 http://www.drugviews.com/articles.php?t=ThermoGenesis-files-Certificate-of-Amendment-for-reverse-stock-split Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.]]> Fri, 27 Aug 2010 01:37:50 -0400 http://www.drugviews.com/articles.php?t=Bioheart-reports-promising-result-for-congestive-heart-failure-treatment-with-stem-cell-therapy Fri, 27 Aug 2010 00:26:27 -0400 http://www.drugviews.com/articles.php?t=NICE-suggests-bortezomib-thalidomide-for-multiple-myeloma-patients A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans.]]> Thu, 26 Aug 2010 06:31:46 -0400 http://www.drugviews.com/articles.php?t=Researchers-show-biosynthetic-cornea-can-stimulate-regeneration-in-damaged-eye-tissue Thu, 26 Aug 2010 04:49:19 -0400 http://www.drugviews.com/articles.php?t=NIH-suspends-funding-new-embryonic-stem-cell-research-following-court-order first successful report of using cell-depleted lung as a natural growth matrix for generating new rat lung from embryonic stem cells is presented in a breakthrough article in Tissue Engineering, Part A, a peer-reviewed journal published by Mary Ann Liebert, Inc..]]> Fri, 20 Aug 2010 06:07:39 -0400 http://www.drugviews.com/articles.php?t=Cell-depleted-lung-used-as-natural-growth-matrix-for-generating-new-rat-lung-from-embryonic-stem-cells be formalized into a new business unit, Cytovis™.]]> Fri, 20 Aug 2010 04:50:33 -0400 http://www.drugviews.com/articles.php?t=ISCO-to-formalize-eye-care-based-stem-cell-therapeutic-programs-into-Cytovis-business-unit chronic spinal cord injury, suggesting the prospect of treating a much broader population of patients.]]> Fri, 20 Aug 2010 04:19:59 -0400 http://www.drugviews.com/articles.php?t=UCI-study-is-first-to-show-reversal-of-long-term-hind-limb-paralysis online journal PLoS One.]]> Thu, 19 Aug 2010 23:47:00 -0400 http://www.drugviews.com/articles.php?t=New-avenues-for-stem-cell-research tissue regeneration.]]> Thu, 19 Aug 2010 05:09:49 -0400 http://www.drugviews.com/articles.php?t=Research-reveals-possibility-to-convert-one-stem-type-to-another-without-genetic-modification one type of cell and transforming it into another type is now possible. Cells taken from the thymus have been transformed into skin cells,a discovery that may have important ramifications for the field of organ regeneration.]]> Thu, 19 Aug 2010 04:10:37 -0400 http://www.drugviews.com/articles.php?t=Discovery-on-stem-cell-can-create-new-opportunity-in-organ-regeneration-field product and service revenues, global research and development capabilities and operations in three distinct business units, U.S. adult stem cells, China adult stem cells, and China pharmaceuticals is today providing results of its second quarter 2010.]]> Mon, 16 Aug 2010 09:22:19 -0400 http://www.drugviews.com/articles.php?t=NeoStem-second-quarter-revenues-increase-26-to-19-4-million NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the Schepens Eye Research Institute, a charitable corporation of Massachusetts and an affiliate of Harvard Medical School.]]> Thu, 12 Aug 2010 01:21:43 -0400 http://www.drugviews.com/articles.php?t=NeoStem-Schepens-Eye-Research-Institute-collaborate-to-develop-therapies-for-AMD-and-Glaucoma care units.]]> Thu, 12 Aug 2010 01:20:37 -0400 http://www.drugviews.com/articles.php?t=Scientists-find-therapeutic-potential-of-stem-cells-for-acute-lung-injury drug discovery, today reported financial results and business highlights for the second quarter ended June 30, 2010.]]> Wed, 11 Aug 2010 02:45:46 -0400 http://www.drugviews.com/articles.php?t=StemCells-second-quarter-net-loss-decreases-to-4-61-million